| 000 | 01680 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513063928.0 | ||
| 264 | 0 | _c19940614 | |
| 008 | 199406s 0 0 eng d | ||
| 022 | _a0021-9738 | ||
| 024 | 7 |
_a10.1172/JCI117216 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKitakaze, M | |
| 245 | 0 | 0 |
_aAlpha 1-adrenoceptor activation mediates the infarct size-limiting effect of ischemic preconditioning through augmentation of 5'-nucleotidase activity. _h[electronic resource] |
| 260 |
_bThe Journal of clinical investigation _cMay 1994 |
||
| 300 |
_a2197-205 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a5'-Nucleotidase _xmetabolism |
| 650 | 0 | 4 | _aAdaptation, Biological |
| 650 | 0 | 4 |
_aAdenosine _xblood |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBlood Pressure |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 |
_aEndocardium _xmetabolism |
| 650 | 0 | 4 |
_aEsophagus _xmetabolism |
| 650 | 0 | 4 | _aHemodynamics |
| 650 | 0 | 4 |
_aMethoxamine _xpharmacology |
| 650 | 0 | 4 |
_aMyocardial Infarction _xenzymology |
| 650 | 0 | 4 |
_aMyocardial Ischemia _xenzymology |
| 650 | 0 | 4 | _aPerfusion |
| 650 | 0 | 4 |
_aPrazosin _xpharmacology |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, alpha-1 _xmetabolism |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aHori, M | |
| 700 | 1 | _aMorioka, T | |
| 700 | 1 | _aMinamino, T | |
| 700 | 1 | _aTakashima, S | |
| 700 | 1 | _aSato, H | |
| 700 | 1 | _aShinozaki, Y | |
| 700 | 1 | _aChujo, M | |
| 700 | 1 | _aMori, H | |
| 700 | 1 | _aInoue, M | |
| 773 | 0 |
_tThe Journal of clinical investigation _gvol. 93 _gno. 5 _gp. 2197-205 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1172/JCI117216 _zAvailable from publisher's website |
| 999 |
_c8181468 _d8181468 |
||